UnitedHealth Group Inc. is facing a class-action lawsuit alleging it misused former employees' 401(k) funds to reduce corporate costs, a claim the company has denied. The lawsuit adds to ongoing scrutiny of the healthcare giant, which has also been accused of paying nursing homes to let seniors die for profitability, and is currently the target of a separate lawsuit by BlackRock alleging it provided patients with excessive care. Despite these legal challenges, UnitedHealth's stock has shown resilience, holding around the $300 level with notable options activity including a $10 million purchase of June 2027 $300 calls. The company’s stock has nearly doubled in value recently, and some investors view it as a strong holding for retirement accounts. Meanwhile, another healthcare company, Tremor Pharmaceuticals ($TEM), saw its shares drop 17% following a short report by Spruce Point Capital, though some investors consider the decline a buying opportunity. The healthcare sector remains under intense scrutiny amid these developments. Additionally, UnitedHealth’s board is reportedly considering a substantial pay package for its new CEO amid the ongoing controversies.